ROQ — Roquefort Therapeutics Share News
0.000.00%
- £2.20m
- £2.40m
- 14
- 49
- 19
- 14
REG - Roquefort Theraptcs. - AGM Statement
AnnouncementRCS - Roquefort Theraptcs. - Investor Presentation via Investor Meet Company
AnnouncementREG - Roquefort Theraptcs. - Director/PDMR Shareholding
AnnouncementREG - Roquefort Theraptcs. - Director/PDMR Shareholding
AnnouncementREG - Roquefort Theraptcs. - Director/PDMR Shareholding
AnnouncementREG - Roquefort Theraptcs. - RNA Medicine Shows In Vitro Anti-Cancer Efficacy
AnnouncementREG - Roquefort Theraptcs. - Antibody Program Results & Orphan Drug Indication
AnnouncementREG - Roquefort Theraptcs. - Anti-Cancer MDK mRNA - Positive in vitro Results
AnnouncementREG - Roquefort Theraptcs. - Restoration of Trading
AnnouncementREG - Roquefort Theraptcs. - Notice of Annual General Meeting
AnnouncementREG - Roquefort Theraptcs. - Annual Report & Financial Statements - 31 Dec 2022
AnnouncementREG - Roquefort Theraptcs. - Suspension of Trading Pending 2022 Annual Report
AnnouncementREG - Official List Roquefort Theraptcs. - Suspension - Roquefort Therapeutics plc
AnnouncementREG - Roquefort Theraptcs. - Confirmation of No Exposure to Silicon Valley Bank
AnnouncementREG - Roquefort Theraptcs. - Creation of New Novel Family of mRNA Therapeutics
AnnouncementREG - Hot Rocks Inv PLC - Interim Results to 30 September 2022
AnnouncementREG - Roquefort Theraptcs. - Formation of Scientific Advisory Board
AnnouncementRCS - Roquefort Theraptcs. - Company Presentation
AnnouncementRCS - Roquefort Theraptcs. - Investor Presentation
Announcement